Sign in
4

Changes in Ownership

Bicara Therapeutics Inc. Filed Acc 0002034668-25-000012

Chief Financial Officer sold 9,200 shares at $18.31 ($168,492)

  • Chief Financial Officer acquired 9,200 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Hyep Ivan · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-22 Exercise or conversion : show line 1 in the form 10b5-1 +9,200 $3.79 $34,866 154,555 D
2025-12-22 Sale : show line 2 in the form 10b5-1 −9,200 $18.31 $168,492 145,355 D
Open-market sales · 9,200 sh · avg $18.31 · $168,492

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-22 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −9,200 88,984 D
Loading xslF345X05/wk-form4_1766523739.xml…